Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis

被引:220
作者
Kitamoto, Y
Tokunaga, H
Tomita, K
机构
[1] Third Dept. of Internal Medicine, Kumamoto University, School of Medicine
[2] Third Dept. of Internal Medicine, Kumamoto University, School of Medicine, Kumamoto 860
关键词
renal organogenesis; glomerular development; organ culture; endogenous vascular endothelial growth factor; neutralizing antibody;
D O I
10.1172/JCI119416
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Homeostasis of body fluid is maintained by the kidneys, which contain two million glomeruli for blood filtration. A glomerulus is formed by growth of Bowman's capsule harmonized with a capillary during kidney development. The vascular endothelial growth factor (VEGF) is an essential angiogenic cytokine, and VEGF deficiency is known to be fatal in mice in early embryonic stages. As secretions of VEGF from cultured kidneys vary according to developmental stages, the role of VEGF in kidney development was studied in vivo by blocking the endogenous VEGF activity with antibody in newborn mice, in which most organs are already developed but kidneys are still developing. The antibody-treated animals showed normal growth but systemic edema. Vessel formation in the superficial renal cortex was disturbed, nephrogenic areas were diminished, and the number of developing nephrons decreased significantly. Many abnormal glomeruli, lacking capillary tufts, were observed in the antibody-treated mice, and VEGF expression in their Bowman's capsule showed a compensatory increase. These results suggest that VEGF mediates communication between the Bowman's capsule and capillary endothelial cells for developing a glomerulus as web as promoting nephrogenesis. In conclusion, VEGF is likely to be an essential molecule far kidney development, and especially for glomerulogenesis.
引用
收藏
页码:2351 / 2357
页数:7
相关论文
共 23 条
  • [1] STRUCTURE AND DEVELOPMENT OF THE GLOMERULAR CAPILLARY WALL AND BASEMENT-MEMBRANE
    ABRAHAMSON, DR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (05): : F783 - F794
  • [3] DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VASCULAR-PERMEABILITY FACTOR) FORMS IN RAT-TISSUES
    BACIC, M
    EDWARDS, NA
    MERRILL, MJ
    [J]. GROWTH FACTORS, 1995, 12 (01) : 11 - 15
  • [4] BERNSTEIN J, 1981, LAB INVEST, V45, P183
  • [5] BREIER G, 1992, DEVELOPMENT, V114, P521
  • [6] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [7] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442
  • [8] ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM
    FONG, GH
    ROSSANT, J
    GERTSENSTEIN, M
    BREITMAN, ML
    [J]. NATURE, 1995, 376 (6535) : 66 - 70
  • [9] SENSITIVE CHEMILUMINESCENCE ENZYME-IMMUNOASSAY FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR IN HUMAN SERUM
    HANATANI, M
    TANAKA, Y
    KONDO, S
    OHMORI, I
    SUZUKI, H
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1995, 59 (10) : 1958 - 1959
  • [10] THE RELATED FLT4, FLT1, AND KDR RECEPTOR TYROSINE KINASES SHOW DISTINCT EXPRESSION PATTERNS IN HUMAN FETAL ENDOTHELIAL-CELLS
    KAIPAINEN, A
    KORHONEN, J
    PAJUSOLA, K
    APRELIKOVA, O
    PERSICO, MG
    TERMAN, BI
    ALITALO, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2077 - 2088